http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104926945-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-59 |
filingDate | 2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104926945-B |
titleOfInvention | A kind of oncotherapy polypeptide and its application with FSHR targetings |
abstract | The present invention provides a kind of oncotherapy polypeptide and its application with FSHR targetings, and the oncotherapy that the polypeptide has FSHR targetings acts on, and the oncotherapy polypeptide of the FSHR targetings is FSH 33‑53 IIKK targeted fusion polypeptides, the polypeptide have the antitumor activity of enhancing IIKK polypeptides.The FSH of the present invention 33‑53 IIKK targeted fusions polypeptide can be applied in treatment or prevention tumour medicine is prepared. |
priorityDate | 2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.